Company Insight – Page 29 – media

FDA approves Malin’s Hourglass peripheral embolization plug

FDA has cleared Irish life sciences company Malin Corp for its Hourglass peripheral embolization plug.
- Source: massdevice
- 561
- August 23, 2017
Company Insight embolization FDA New Approvals peripheral
AstraZeneca announces new mRNA collaboration

A five-year strategic research collaboration between AstraZeneca and its global biologics research and development arm MedImmune and Ethris, a company focussed on mRNA-based therapeutics with specific expertise in pulmonary disease.
- Source: pharmatimes
- 804
- August 22, 2017
asthma chronic collaboration Company Insight mRNA therapy
J&J’s Ethicon launches ProxiSure laparoscopic suturing device

The ProxiSure laparoscopic suturing device was launched, said Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon.
- Source: massdevice
- 521
- August 22, 2017
Company Insight FDA laparoscopic suturing
US regulators wave through Pfizer’s leukaemia drug

Pfizer’s Besponsa has been approved by the US Food and Drug Administration (FDA). It's the first and only CD22-directed antibody-drug conjugate indicated to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).
- Source: pharmatimes
- 1,046
- August 21, 2017
ALL antibody Company Insight FDA New Approvals
HeartSciences gets CE mark for MyoVista hsECG testing device

MyoVista hsECG testing device has been developed for front-line screening of cardiac disease in both symptomatic and asymptomatic patients.
- Source: medicaldevices
- 607
- August 21, 2017
cardiac CE Company Insight CWT hsECG
GSK opens new aluminium salts facility in Scotland

Being set to supply ingredients for around 400 million vaccines a year, a new £44 million aluminium salts facilityhas been officially opened by GlaxoSmithKline in Montrose, Scotland.
- Source: news.open-medical
- 622
- August 17, 2017
aluminium salt Company Insight HIV ingredient respiratory vaccine
VentureMed raises $15m in Series B

Vascular focused device developer VentureMed said today it raised $15 million in a Series B round.
- Source: massdevice
- 503
- August 16, 2017
Company Insight Market Views medical device peripheral artery Series
Atlas awarded £2m grant for infectious disease test

In support of the project in adopting Atlas Genetic's io rapid diagnostic platform into UK sexual health clinics, Innovative UK has awarded them a grant of £2 million.
- Source: news.open-medical
- 435
- August 16, 2017
Company Insight diagnostic infectious
FDA approves Renovis Surgical’s 3D-printed posterior lumbar interbody fusion systems

The clearance for 3D-printed Tesera porous titanium interbody fusion systems has been secured from the US Food and Drug Administration (FDA) by Renovis Surgical Technologies.
- Source: orthopedicdevices
- 426
- August 15, 2017
Company Insight FDA interbody lumbar New Approvals
£2m UK consortium to tackle gene therapy

A two-year, £2 million project focused on gene and cell therapy manufacturing will be embarked on by Oxford BioMedica, will embark on.
- Source: news.open-medical
- 501
- August 14, 2017
cell Company Insight gene therapy

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.